Clinical and microbiological effectiveness of limosilactobacillus reuteri in supportive periodontal therapy: randomized clinical trial
Whilst L. reuteri cannot be recommended as a standard adjunctive therapy in SPT, it can be considered to reduce BOP levels in patients with poor plaque control.
Authors
- Magda Mensi (ORCID: https://orcid.org/0000-0001-5807-9338)
- Stefano Calza (ORCID: https://orcid.org/0000-0003-4996-7995)
- G. G. Garzetti
- Annamaria Sordillo (ORCID: https://orcid.org/0000-0001-7004-1885)
- M.J. Buijs (ORCID: https://orcid.org/0000-0003-4746-4104)
- Bernd W. Brandt (ORCID: https://orcid.org/0000-0002-1155-1989)
- Egija Zaura (ORCID: https://orcid.org/0000-0003-1432-6194)
- Silvia Marchetti
- Eleonora Scotti
Institutions
- Academic Center for Dentistry Amsterdam (NL)
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT)
- University of Brescia (IT)
- Vrije Universiteit Amsterdam (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- Clinical Oral Investigations
- Published
- 2025-08-26
- DOI
- https://doi.org/10.1007/s00784-025-06508-w
- Primary Topic
- Oral microbiology and periodontitis research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Università degli Studi di Brescia